XML 79 R56.htm IDEA: XBRL DOCUMENT v3.23.2
Acquisitions and Divestitures - Narrative (Details) - USD ($)
$ / shares in Units, $ in Millions
3 Months Ended 6 Months Ended 12 Months Ended
Dec. 22, 2022
Apr. 02, 2023
Jul. 02, 2023
Jan. 01, 2023
Business Acquisition [Line Items]        
Useful life (in years) 14 years      
Acquisition related costs     $ 100 $ 300
Goodwill, related to acquisitions     0  
Contingent consideration     $ 1,142 $ 1,120
Goodwill, Purchase Accounting Adjustments   $ 100    
Non-Tradeable Contingent Value Right        
Business Acquisition [Line Items]        
Dividends payable (in dollars per share) $ 8.75      
Non-Tradeable Contingent Value Right | Class I Recommendation For Impella        
Business Acquisition [Line Items]        
Dividends payable (in dollars per share) 10.00      
ABIOMED(3)        
Business Acquisition [Line Items]        
Share price (in dollars per share) $ 380.00      
Consideration transferred $ 17,100      
Cash, cash equivalents, and marketable securities acquired 16,500      
Assets acquired 19,900      
Cash acquired from acquisition 300      
Total amortizable intangibles 6,600      
In-process research and development 1,100      
Marketable securities 600      
Liabilities assumed 2,800      
Deferred tax liabilities $ 1,800      
Discount rate 9.50%      
Goodwill, related to acquisitions $ 10,900      
Contingent consideration $ 700      
ABIOMED(3) | Minimum        
Business Acquisition [Line Items]        
Probability of success factor 52.00%      
ABIOMED(3) | Maximum        
Business Acquisition [Line Items]        
Probability of success factor 70.00%      
ABIOMED(3) | Non-Tradeable Contingent Value Right        
Business Acquisition [Line Items]        
Contingent value right (in dollars per share) $ 35.00      
Contingent value right $ 1,600      
Dividends payable (in dollars per share) $ 17.50      
Revenues $ 3,700      
ABIOMED(3) | Non-Tradeable Contingent Value Right | Impella        
Business Acquisition [Line Items]        
Dividends payable (in dollars per share) $ 7.50